PolyPid
PYPD | NASDAQ
$6.15
-$0.11 (-1.76%)
At close: Nov 16, 2026, 4:00 PM ET
$6.15
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-1.76%
(1D)No price chart data available for 1D timeframe.
Rating
38
-5.0 ptsFundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #577/1021 (Top 57%)
Key Statistics
Market Data
Market Cap $145.62M
1D Range
6.07 6.25
52W Range
3.60 6.60
Valuation (TTM)
PE -4.56
PB 37.33
EV/EBITDA -4.27
Valuation (NTM)
Forward PE 51.02
Forward PEG 0.10
Price Target $12.00
Cash Flow
FCF Yield 0.0%
SBC Adj. FCF Yield 0.0%
SBC Impact N/A
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 79.1% |
86.5%
FCF 3Y | 5Y 66.3% |
100.0%
Returns
ROA -74.3%
ROE -410.5%
ROIC 0.4%
Financial Health
Net Cash
$14.67M
Current Ratio 5.94
Interest Coverage 6.21
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
PolyPid Ltd. is an advanced-stage biopharmaceutical company specializing in the development, manufacturing, and commercialization of therapeutic solutions. These solutions are based on its proprietary...
Sector Healthcare
Industry Biotechnology
Employees 72
IPO Date Jun 26, 2020
Website www.polypid.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 11, 2026
EPS
-$0.24
Miss -126.29%
YoY:
+35.14% REV
$30M
Beat 0.00%
Next Earnings
Feb 10, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$12.00
Upside
+95.12%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove PYPD